Newron Pharmaceuticals
NWRN.SW
#8290
Rank
A$0.27 B
Marketcap
$14.40
Share price
-0.74%
Change (1 day)
89.43%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.73

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.73. In 2023 the company made an earnings per share (EPS) of -$1.73 a decrease over its 2022 EPS that were of -$1.69.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.732.03%
2022-$1.6915.39%
2021-$1.47-31.32%
2020-$2.1414.74%
2019-$1.8636.6%
2018-$1.36159.87%
2017-$0.53-67.81%
2016-$1.63-39.24%
2015-$2.68107.61%
2014-$1.2915.8%
2013-$1.12119.91%
2012-$0.51-66.51%
2011-$1.52-71.49%
2010-$5.32-10.83%
2009-$5.9642.06%
2008-$4.2056.53%
2007-$2.68-52.84%
2006-$5.69-188.53%
2005$6.42